Shares of Cembra Money Bank dropped sharply today, falling 7.5% to CHF 82.45 during trading. The decline came after UBS downgraded the stock from Neutral to Sell and slashed its price target to CHF 78 from CHF 91.70. The move triggered a wave of selling, pushing the stock to a two-year low.
UBS analysts argued that Cembra has limited ability to sustainably exceed its medium-term 15% return-on-equity goal. They also warned of rising credit losses due to slow growth in Swiss consumer finance. Additionally, the bank highlighted interest rate risk, noting that any tightening by the Swiss National Bank could increase refinancing costs and squeeze margins.
The downgrade comes ahead of Cembra’s Investor Day on December 3 in Zürich, leaving investors uncertain about potential strategic updates from management. The broader Swiss equity market also opened weakly, with defensive stocks like Roche and Novartis weighing on the main index.
The combination of UBS’s sell rating, a lower price target, and a cautious macro backdrop for Swiss consumer lenders drove today’s sharp decline, which also brought the stock to its 52-week low of CHF 81.25 intraday.